The Latest Cardiac and Vascular News
BOSTON–(BUSINESS WIRE)–Cardurion Pharmaceuticals, Inc. (Cardurion), a Boston-based, clinical-stage biotechnology company focused on discovering and developing next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced the appointment of Peter S. Lawrence as president and chief executive officer. Mr. Lawrence joins Cardurion after serving for almost 14 years […]
Swedish Heart-Lung Home Monitor Expands Indications for use in COVID-19 Respiratory Diagnostic Exams IRVINE, Calif., April 15, 2020 /PRNewswire/ — Coala Life, a leading Swedish digital health company has, as supported by FDA’s Emergency Guidance, expanded the indication for use enabling physicians to remotely, in real-time, monitor patients’ hearts and lung sounds. The Coala […]
FAIRWAY, Kan., April 14, 2020 /PRNewswire/ — Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets has appointed seasoned medical device sales executive Jeff Weinrich to its Board of Directors. Weinrich is currently on the Senior Regional Management Team at Corindus Vascular Robotics, […]
Intact Vascular’s Tack Endovascular System is a First-of-its-Kind Vascular Implant for Optimized Balloon Angioplasty Outcomes in Challenging CLI Patient Population WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and Drug Administration (FDA) approval for the Tack […]
Former FDA Medical Officer and digital health innovator joins executive team during time of transformation in digital health OAKLAND, Calif.–(BUSINESS WIRE)–Eko today announced the appointment of Adam Saltman, M.D., Ph.D., to the position of Chief Medical Officer (CMO). Dr. Saltman will assume responsibility for leading Eko’s overall clinical development and medical […]
Availability of the two-lead device represents a significant advancement in the development of cardiac contractility modulation therapy for patients with heart failure MT. LAUREL, N.J.–(BUSINESS WIRE)–Impulse Dynamics, a medical device company dedicated to improving the lives of heart failure patients, today announced the publication of the FIX-HF-5C2 study in Circulation: Heart […]
CareDx Announces Collaborations to Develop Cellular Therapy Diagnostics SOUTH SAN FRANCISCO, Calif., April 14, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today a biopharma research partnership […]
SAN CARLOS, Calif., April 14, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported it has entered into an agreement for litigation financing which has been filed today with the Securities and Exchange Commission on Form 8-K. BioCardia, Inc. […]
Top-line Results for GALACTIC-HF Expected in Q4 2020; Enrollment in METEORIC-HF Temporarily Suspended SOUTH SAN FRANCISCO, Calif., April 14, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today provided an update regarding the company’s clinical trials and business operations related to its response to the COVID-19 pandemic alongside its commitment to […]
– Sales of $20.7 billion reflecting strong growth of 3.3%, operational growth of 4.8%* and adjusted operational growth of 5.6%*, inclusive of the overall estimated negative impact of the COVID-19 pandemic – EPS of $2.17 increased 56.1%; adjusted EPS of $ 2.30 increased 9.5%* – Dividend increase of 6.3% announced […]
